Autopsy report · NCT00271245
Selenium Supplementation of Patients With Cirrhosis
Cause of deathFunding or business
“Insufficient funds to complete study.”
Life of this trial
- Registered 2 months before it started.
- Ran for about 6 years 1 month before it stopped.
- 99 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Vanderbilt University
- Sponsor type
- University, hospital or other
- Conditions
- Liver Disease
- Interventions
- 200 µg selenium as selenate; 400 µg selenium as selenate; 200 µg selenium as selenomethionine; Placebo
- Participants
- 99
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Study of EQU-001 for Uncontrolled Focal Onset Seizures
“insufficient funding to complete the study” - Health Education for Physiotherapy in Soccer Players
“The study was stopped by insufficient funds” - Midodrine Use in Septic Shock
“No funding for the study; not enough staff” - Safety & Efficacy of Intranasal Dexmedetomidine, Fentanyl & Midazolam in the Pediatric Emergency Room
“Unable to obtain funding to initiate/complete study” - Home-based SSP on Individuals With PWS
“Insufficient resources to complete study as planned”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.